Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats
Language English Country Czech Republic Media print-electronic
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
17824802
DOI
10.33549/physiolres.931402
PII: 1402
Knihovny.cz E-resources
- MeSH
- Acetylcholine pharmacology MeSH
- Antihypertensive Agents administration & dosage pharmacology MeSH
- Femoral Artery drug effects physiopathology MeSH
- Diuretics pharmacology MeSH
- Hydrochlorothiazide pharmacology MeSH
- Hypertension chemically induced complications physiopathology prevention & control MeSH
- Hypertrophy, Left Ventricular etiology physiopathology prevention & control MeSH
- Indapamide pharmacology MeSH
- Angiotensin-Converting Enzyme Inhibitors pharmacology MeSH
- Captopril pharmacology MeSH
- Drug Therapy, Combination MeSH
- Blood Pressure drug effects MeSH
- Rats MeSH
- Disease Models, Animal MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Nitric Oxide metabolism MeSH
- Rats, Wistar MeSH
- Drug Administration Schedule MeSH
- Heart Ventricles drug effects pathology MeSH
- Drug Synergism MeSH
- Body Weight drug effects MeSH
- Vasodilation drug effects MeSH
- Vasodilator Agents pharmacology MeSH
- Organ Size drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Acetylcholine MeSH
- Antihypertensive Agents MeSH
- Diuretics MeSH
- Hydrochlorothiazide MeSH
- Indapamide MeSH
- Angiotensin-Converting Enzyme Inhibitors MeSH
- Captopril MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Nitric Oxide MeSH
- Vasodilator Agents MeSH
We aimed to compare the effects of chronic and acute administration of structurally different antihypertensives, diuretics - indapamide and hydrochlorothiazide, ACE inhibitor - captopril and indapamide+captopril combination on endothelium-dependent relaxation of femoral artery isolated from nitric oxide (NO)-deficient rats. In the chronic experiment, femoral artery was isolated from Wistar rats receiving L-NAME (40 mg/kg/day) solely or with indapamide (1 mg/kg/day), hydrochlorothiazide (10 mg/kg/day), captopril (10 mg/kg/day), and indapamide+captopril combination for seven weeks. In the acute in vitro experiment, the incubation medium with femoral artery isolated from L-NAME-hypertensive rats was supplemented with investigated antihypertensives in the same concentration 10(-4) mol/l. Interestingly, chronic L-NAME treatment did not cause a reduction of vasorelaxation. Indapamide+captopril elevated relaxation above the control level and completely prevented blood pressure increase induced by L-NAME. Acute incubation with captopril only or indapamide+captopril improved relaxation of femoral artery isolated from L-NAME-hypertensive rats, while the incubation with all antihypertensives increased vasorelaxation of femoral artery isolated from control Wistar rats. In conclusion, NO might be involved in the indapamide- and hydrochlorothiazide-induced improvement of vasorelaxation, while different vasorelaxing factors (prostacyclin, EDHF) contribute to the captopril-induced improvement of vasorelaxation. During the chronic treatment additive and synergic effects of indapamide and captopril may contribute to the prevention of hypertension and increase of vasorelaxation.
References provided by Crossref.org